Bioethics (BOTH) Stock Statistics & Valuation Metrics

Bioethics has a market cap or net worth of $18.36K. The enterprise value is $589.38K.

Bioethics has 3,600,194 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bioethics’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 35.54%.

The current PE Ratio of Bioethics is ―. Bioethics’s PEG ratio is -0.24.

In the last 12 months, Bioethics had revenue of 0.00 and earned -176.96K in profits. Earnings per share was -0.12.

In the last 12 months, operating cash flow was -150.43K and capital expenditures 0.00, giving a free cash flow of -150.43K billion.

Bioethics pays an annual dividend of ―, resulting in a dividend yield of ―

Bioethics upcoming earnings date is ―, ―.

Bioethics as a current ratio of 0.02, with Debt / Equity ratio of -62.89%

In the past 12 months, Bioethics has paid 0.00 in taxes.

Bioethics EV to EBITDA ratio is -18.63, with an EV/FCF ratio of -15.21.

Bioethics has $14.66K in cash and marketable securities with $585.69K in debt, giving a net cash position of -$571.02K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Bioethics is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy